Cable Viewer

Currently released so far... 12856 / 251,287

### Browse latest releases

2010/11 2010/12 2011/01 2011/02 2011/03 2011/04 2011/05
2010/11/28 2010/11/29 2010/11/30
2010/12/01 2010/12/02 2010/12/03 2010/12/04 2010/12/05 2010/12/06 2010/12/07 2010/12/08 2010/12/09 2010/12/10 2010/12/11 2010/12/12 2010/12/13 2010/12/14 2010/12/15 2010/12/16 2010/12/17 2010/12/18 2010/12/19 2010/12/20 2010/12/21 2010/12/22 2010/12/23 2010/12/24 2010/12/25 2010/12/26 2010/12/27 2010/12/28 2010/12/29 2010/12/30
2011/01/01 2011/01/02 2011/01/04 2011/01/05 2011/01/07 2011/01/09 2011/01/10 2011/01/11 2011/01/12 2011/01/13 2011/01/14 2011/01/15 2011/01/16 2011/01/17 2011/01/18 2011/01/19 2011/01/20 2011/01/21 2011/01/22 2011/01/23 2011/01/24 2011/01/25 2011/01/26 2011/01/27 2011/01/28 2011/01/29 2011/01/30 2011/01/31
2011/02/01 2011/02/02 2011/02/03 2011/02/04 2011/02/05 2011/02/06 2011/02/07 2011/02/08 2011/02/09 2011/02/10 2011/02/11 2011/02/12 2011/02/13 2011/02/14 2011/02/15 2011/02/16 2011/02/17 2011/02/18 2011/02/19 2011/02/20 2011/02/21 2011/02/22 2011/02/23 2011/02/24 2011/02/25 2011/02/26 2011/02/27 2011/02/28
2011/03/01 2011/03/02 2011/03/03 2011/03/04 2011/03/05 2011/03/06 2011/03/07 2011/03/08 2011/03/09 2011/03/10 2011/03/11 2011/03/13 2011/03/14 2011/03/15 2011/03/16 2011/03/17 2011/03/18 2011/03/19 2011/03/20 2011/03/21 2011/03/22 2011/03/23 2011/03/24 2011/03/25 2011/03/26 2011/03/27 2011/03/28 2011/03/29 2011/03/30 2011/03/31
2011/04/01 2011/04/02 2011/04/03 2011/04/04 2011/04/05 2011/04/06 2011/04/07 2011/04/08 2011/04/09 2011/04/10 2011/04/11 2011/04/12 2011/04/13 2011/04/14 2011/04/15 2011/04/16 2011/04/17 2011/04/18 2011/04/19 2011/04/20 2011/04/21 2011/04/22 2011/04/23 2011/04/24 2011/04/25 2011/04/26 2011/04/27 2011/04/28 2011/04/29 2011/04/30
2011/05/01 2011/05/02 2011/05/03 2011/05/04 2011/05/05 2011/05/06 2011/05/07 2011/05/08 2011/05/09 2011/05/10 2011/05/11 2011/05/12 2011/05/13 2011/05/14 2011/05/15 2011/05/16 2011/05/17 2011/05/18 2011/05/19 2011/05/20 2011/05/21 2011/05/22 2011/05/23

### Browse by creation date

66 72 73 75 79 85 86 87 88 89 90 91 92 93 94 96 97 00 01 02 03 04 05 06 07 08 09 10
1966/12
1972/02 1972/08
1973/04
1975/03
1979/08
1985/03 1985/05 1985/06
1986/05
1987/06
1988/01 1988/03 1988/07
1989/12
1990/01 1990/07 1990/08 1990/10
1991/05
1992/01 1992/03 1992/06 1992/09 1992/12
1993/01 1993/10
1994/12
1996/07 1996/11
1997/06 1997/12
2000/05 2000/06 2000/09 2000/11
2001/02 2001/03 2001/06 2001/07 2001/09 2001/10 2001/11
2002/01 2002/02 2002/03 2002/04 2002/07 2002/08 2002/09 2002/11 2002/12
2003/01 2003/02 2003/03 2003/04 2003/05 2003/06 2003/07 2003/08 2003/09 2003/10 2003/11 2003/12
2004/01 2004/02 2004/03 2004/04 2004/05 2004/06 2004/07 2004/08 2004/09 2004/10 2004/11 2004/12
2005/01 2005/02 2005/03 2005/04 2005/05 2005/06 2005/07 2005/08 2005/09 2005/10 2005/11 2005/12
2006/01 2006/02 2006/03 2006/04 2006/05 2006/06 2006/07 2006/08 2006/09 2006/10 2006/11 2006/12
2007/01 2007/02 2007/03 2007/04 2007/05 2007/06 2007/07 2007/08 2007/09 2007/10 2007/11 2007/12
2008/01 2008/02 2008/03 2008/04 2008/05 2008/06 2008/07 2008/08 2008/09 2008/10 2008/11 2008/12
2009/01 2009/02 2009/03 2009/04 2009/05 2009/06 2009/07 2009/08 2009/09 2009/10 2009/11 2009/12
2010/01 2010/02

### Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z
Embassy Athens Embassy Asuncion Embassy Astana Embassy Asmara Embassy Ashgabat Embassy Apia Embassy Ankara Embassy Amman Embassy Algiers Embassy Addis Ababa Embassy Accra Embassy Abuja Embassy Abu Dhabi Embassy Abidjan Consulate Auckland Consulate Amsterdam Consulate Adana American Institute Taiwan, Taipei
Embassy Bujumbura Embassy Buenos Aires Embassy Budapest Embassy Bucharest Embassy Brussels Embassy Bridgetown Embassy Bratislava Embassy Brasilia Embassy Bogota Embassy Bishkek Embassy Bern Embassy Berlin Embassy Belmopan Embassy Belgrade Embassy Beirut Embassy Beijing Embassy Banjul Embassy Bangkok Embassy Bandar Seri Begawan Embassy Bamako Embassy Baku Embassy Baghdad Consulate Barcelona
Embassy Copenhagen Embassy Conakry Embassy Colombo Embassy Chisinau Embassy Caracas Embassy Canberra Embassy Cairo Consulate Curacao Consulate Ciudad Juarez Consulate Chennai Consulate Casablanca Consulate Cape Town Consulate Calgary
Embassy Dushanbe Embassy Dublin Embassy Doha Embassy Djibouti Embassy Dili Embassy Dhaka Embassy Dar Es Salaam Embassy Damascus Embassy Dakar Consulate Dubai
Embassy Freetown Consulate Fukuoka
Embassy Guatemala Embassy Gaborone Consulate Guayaquil Consulate Guadalajara
Embassy Helsinki Embassy Harare Embassy Hanoi Consulate Ho Chi Minh City Consulate Hermosillo Consulate Hamilton Consulate Hamburg Consulate Halifax
Iran RPO Dubai Embassy Islamabad Consulate Istanbul
Embassy Jakarta Consulate Jerusalem Consulate Jeddah
Embassy Kyiv Embassy Kuwait Embassy Kuala Lumpur Embassy Kinshasa Embassy Kingston Embassy Kigali Embassy Khartoum Embassy Kathmandu Embassy Kampala Embassy Kabul Consulate Kolkata Consulate Karachi
Embassy Luxembourg Embassy Luanda Embassy London Embassy Ljubljana Embassy Lisbon Embassy Lima Embassy Lilongwe Embassy La Paz Consulate Lahore Consulate Lagos
Mission USOSCE Mission USNATO Mission UNESCO Embassy Muscat Embassy Moscow Embassy Montevideo Embassy Monrovia Embassy Minsk Embassy Mexico Embassy Mbabane Embassy Maputo Embassy Manila Embassy Manama Embassy Managua Embassy Malabo Embassy Madrid Consulate Munich Consulate Mumbai Consulate Montreal Consulate Monterrey Consulate Milan Consulate Melbourne
Embassy Nicosia Embassy Niamey Embassy New Delhi Embassy Ndjamena Embassy Nassau Embassy Nairobi Consulate Naples Consulate Naha
Embassy Ouagadougou Embassy Ottawa Embassy Oslo
Embassy Pristina Embassy Pretoria Embassy Prague Embassy Port Of Spain Embassy Port Louis Embassy Port Au Prince Embassy Phnom Penh Embassy Paris Embassy Paramaribo Embassy Panama Consulate Peshawar
Embassy Quito Consulate Quebec
REO Basrah Embassy Rome Embassy Riyadh Embassy Riga Embassy Reykjavik Embassy Rangoon Embassy Rabat Consulate Rio De Janeiro Consulate Recife
Secretary of State Embassy Suva Embassy Stockholm Embassy Sofia Embassy Skopje Embassy Singapore Embassy Seoul Embassy Sarajevo Embassy Santo Domingo Embassy Santiago Embassy Sanaa Embassy San Salvador Embassy San Jose Consulate Strasbourg Consulate St Petersburg Consulate Shenyang Consulate Shanghai Consulate Sapporo Consulate Sao Paulo
Embassy Tunis Embassy Tripoli Embassy Tokyo Embassy The Hague Embassy Tel Aviv Embassy Tehran Embassy Tegucigalpa Embassy Tbilisi Embassy Tashkent Embassy Tallinn Consulate Toronto Consulate Tijuana
USUN New York USEU Brussels US Office Almaty US Mission Geneva US Interests Section Havana US Delegation, Secretary UNVIE Embassy Ulaanbaatar
Embassy Vilnius Embassy Vienna Embassy Vatican Embassy Valletta Consulate Vladivostok Consulate Vancouver
Embassy Windhoek Embassy Wellington Embassy Warsaw
Embassy Yerevan Embassy Yaounde
Embassy Zagreb

### Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
AVERY AMGT AR ASEC AMED AORC AG AU AM APEC ABUD AF AS AGRICULTURE AEMR ASEAN APECO ACOA AJ AO AFIN ABLD ADPM AY ASCH AE AFFAIRS AA AC ARF APER AFU AINF AODE AMG ATPDEA AGAO ASECKFRDCVISKIRFPHUMSMIGEG AID AL AORL AFSI AFSN ADCO ASUP AN AIT ANET ASIG AGMT ADANA AADP ACS AGR AMCHAMS AECL AUC AFGHANISTAN ADM ACAO AND ATRN ALOW APCS AORG AROC ACABQ AX AMEX AZ ARM AQ ATFN AMBASSADOR ACBAQ ASEX AER
BR BA BO BL BK BT BD BU BBSR BMGT BM BY BX BTIO BEXP BG BB BH BF BP BWC BRUSSELS BN BTIU BIDEN BE BILAT BC
CA CS CASC CO CI CD CH CN CY CONDOLEEZZA CU CE CVIS CG CMGT CF CPAS CDC CW CJAN CJUS CTM CM CFED CODEL CWC CR CBW CAN CLMT CBC CONS COUNTERTERRORISM CIA CDG CIC COUNTER CT CNARC CACM CB CV CIDA CLINTON CHR COE CIS CBSA CEUDA CAC CL CACS CAPC CTR COM CROS CARSON COPUOS CICTE CYPRUS COUNTRY CBE CKGR CVR CITEL CLEARANCE CARICOM CSW CITT CDB
DA DR DTRA DEA DHS DJ DO DEAX DAO DCM DE DOD DOMESTIC DK DPRK DEPT DISENGAGEMENT DOE DS DEFENSE
EUN ECON ELAB ETRD EFIN ECIN EAGR EAIR EN EG ECA ET ER EWWT EIND EINV EAID EC EU EFIS ETTC EPET ENRG EMIN ECPS ENGR EINVETC ELTN ECONCS EZ ES EI ECONOMIC ELN EINT EPA ETRA EXTERNAL ESA ETRDEINVECINPGOVCS EAIG EUR EK EUMEM EUREM EUC ENERG ERD EFTA ETRC ETRN EINVECONSENVCSJA EEPET EUNCH ESENV ENNP ENVI ECINECONCS ELECTIONS ENVR ENIV ETRO ETRDECONWTOCS ECUN EXIM EFINECONCS ECONOMY ERNG EINVEFIN ETC EAP EINN EXBS ENGY ECONOMICS EIAR EINDETRD ECONEFIN EURN EDU ETRDEINVTINTCS ECIP EFIM EAIDS EREL
FI FR FTA FTAA FBI FAC FJ FM FDA FARC FAO FO FOR FMLN FISO FAS FREEDOM FOREIGN FINANCE FINR FOI
GV GA GG GE GM GH GTIP GT GZ GAERC GR GOI GCC GOV GY GANGS GERARD GTMO GL GF GAZA GLOBAL
HK HUMAN HA HO HR HU HURI HILLARY HYMPSK HSTC HEBRON HUMOR HI
IV IS IC IIP IR ICRC IZ IWC IAEA IT IN IRS ICAO IQ IMO ILC IMF ILO IF ITPHUM IL IO ID ISRAEL IACI INMARSAT IPR ICTY ICJ INDO IA IDA IBRD IAHRC ISLAMISTS IGAD ITU ITF INRA INRO INRB ITALY IBET INTELSAT ISRAELI IDP ICTR ITRA IRC IRAQI IEFIN ITPGOV ITALIAN INTERNAL INTERPOL IEA INR IZPREL IRAJ
JA JP JO JM JOSEPH JUS JAMES JOHN JOHNNIE
KPAO KV KGIT KPAL KDEM KCRM KISL KPKO KSCA KOMC KTFN KNNP KN KZ KIPR KE KCIP KWMN KGIC KTIA KFRD KHDP KSEP KMPI KG KIRF KJUS KWBG KHLS KCOR KMDR KU KTDB KTIP KS KFLU KGHG KRAD KSPR KHIV KCOM KAID KOM KUNR KRVC KICC KBTS KSUM KOLY KAWC KIRC KDRG KCRS KNPP KSTH KWNM KRFD KVIR KLIG KFLO KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KVPR KTEX KTER KRGY KCFE KIDE KSTC KREC KR KPAONZ KIFR KOCI KBTR KBIO KMCA KGCC KACT KMRS KAWK KSAC KWMNCS KNEI KPOA KSEO KFIN KWAC KNAR KPLS KPAK KSCI KPRP KOMS KBCT KPWR KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KRIM KDDG KPRV KSAF KCGC KPAI KFSC KMFO KID KMIG KVRP KNSD KMOC KTBT KENV KCMR KWMM KHSA KO KX KCRCM KNUP KNUC KNNPMNUC KERG KTLA KCSY KTRD KJUST KRCM KCFC KCHG KREL KFTFN KDEMAF KICA KHUM KSEC KPIN KESS KDEV KWWMN
LY LE LH LABOR LI LG LO LA LU LOG LTTE LAB LT
MARR MOPS MO MASS MX MA MR MNUC MCAP MAPS MD MV MTCRE MY MP ML MILITARY MEPN MARAD MDC MU MEPP MIL MAPP MZ MT MASSMNUC MK MTCR MUCN MAS MEDIA MAR MI MQADHAFI MPOS MG MPS MW MC MTRE MRCRE MASC MOPPS MTS MLS MILI MEPI MEETINGS MERCOSUR MCC MIK
NATO NL NI NZ NG NO NP NK NU NDP NPT NSF NR NAFTA NATOPREL NS NEW NA NE NSSP NSC NH NV NPA NSFO NT NW NASA NSG NORAD NATIONAL NPG NGO NIPP NZUS NC NRR NAR
OEXC OVIP OTRA ODIP OFDP OPDC OPIC OIIP OPRC OAS OREP OSCE OECD OPCW OSCI OMIG OVP OIE ON OCII OPAD OBSP OFFICIALS OES OCS OIC OHUM OTR OSAC OFDA
PTER PREL PE PHUM PGOV PARM PINR PREF PINS PBTS PA PK PM PL PO POL PROP PSOE PHSA PAK PY PLN PMAR PHUH PBIO PF PHUS PTBS PU PNAT POLITICAL PARTIES PCUL PGGV PAO PSA PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PAS PGIV PHUMPREL POGOV PEL PP PINL PBT PG PINF PRL PALESTINIAN PSEPC POSTS PAHO PROV PHUMPGOV POV PGOC PNR PREFA PMIL PREO POLITICS POLICY PDOV PCI PRAM PSI PAIGH PJUS PARMS PROG PTERE PRGOV PORG PS PGOF PKFK PEPR PPA PINT PRELP PNG PFOR PUNE PGOVLO PHUMBA POLINT PGOVE PHALANAGE PARTY PDEM PECON
QA
RS RU RW RIGHTSPOLMIL RICE RUPREL RIGHTS RO RF RELATIONS RP RM RFE REGION REACTION REPORT RCMP RSO ROOD ROBERT RSP
SCUL SNAR SP SENV SU SO SMIG SOCI SW SA SZ SY SL SENVKGHG SF SR SN SARS SANC SHI SIPDIS SEVN SHUM SC SI STEINBERG SK SH SNARCS SPCE SNARN SG SYRIA SNARIZ SWE SIPRS SYR SAARC SEN SCRS SAN ST SSA SPCVIS SOFA
TSPL TBIO TU TH TP TRGY TPHY TZ TW TX TSPA TFIN TC TI TS TAGS TK TIP TNGD TL TV TT TINT TERRORISM TR TN TD TBID TF THPY TO TRSY TURKEY
UN UNSC UK US UNGA UNDP UP UG USTR UNHRC UY UNESCO UNMIK UNEP UZ UNO UNHCR USEU UNAUS UNCHR UNPUOS UNDC UNICEF UNCHC UNCSD USOAS UNFCYP UNIDROIT UV UNCND USUN USNC USPS USAID UE UNVIE UAE UNODC UNCHS UNFICYP UNDESCO UNC
VZ VM VE VT VAT VC VI VTPREL VN VTIZ VTEG
WS WHA WHO WTRO WIPO WEU WZ WTO WMO WA WWARD WHTI WTRQ WBG WFP WB WI WMD WITH
XA XR XM XG XW XB XV XF XD XS XK XY XC XL XZ XX XU XI XT XH XQ XE XTAG
YI YM YE YMCS
ZI ZF ZU ZR ZK ZANU ZB ZEALAND ZP ZO ZL ZOELLICK ZJ ZN ZA

### Browse by classification

CONFIDENTIAL CONFIDENTIAL//NOFORN SECRET SECRET//NOFORN UNCLASSIFIED UNCLASSIFIED//FOR OFFICIAL USE ONLY

### Community resources

Follow us on Twitter Check our Reddit Twitter this Digg this page Contact us on IRC

courage is contagious

### Viewing cable 06WELLINGTON475, INDUSTRY SEES HIGHER COSTS UNDER NEW ZEALAND-AUSTRALIA

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs
Understanding cables
Every cable message consists of three parts:

- The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
- The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
- The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.

To understand the justification used for the classification of each cable, please use this WikiSource article as reference.
Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #06WELLINGTON475.

Reference ID | Created | Released | Classification | Origin
--- | --- | --- | --- | ---
06WELLINGTON475 | 2006-06-21 23:14 | 2011-04-28 00:00 | UNCLASSIFIED//FOR OFFICIAL USE ONLY | Embassy Wellington

`

    VZCZCXRO6701
    RR RUEHNZ
    DE RUEHWL #0475/01 1722314
    ZNR UUUUU ZZH
    R 212314Z JUN 06
    FM AMEMBASSY WELLINGTON
    TO RUEHC/SECSTATE WASHDC 2921
    INFO RUCPDOC/USDOC WASHDC 0062
    RUEHNZ/AMCONSUL AUCKLAND 0791
    RUEHBY/AMEMBASSY CANBERRA 4458
    RUEHDN/AMCONSUL SYDNEY 0448

` `

    UNCLAS SECTION 01 OF 02 WELLINGTON 000475

    SIPDIS

    SENSITIVE
    SIPDIS

    STATE PASS USTR-JJENSEN
    STATE PASS FDA FOR OFFICE OF INTERNATIONAL PROGRAMS
    STATE FOR EAP/ANP-DRICCI AND EB/TPP/BTA/ANA-MBGOODMAN
    COMMERCE FOR ABENAISSA/4530/ITA/MAC/AP/OSAO
    SYDNEY FOR CS

    E.O. 12958: N/A
    TAGS: ETRD ECON NZ
    SUBJECT: INDUSTRY SEES HIGHER COSTS UNDER NEW ZEALAND-AUSTRALIA
    REGULATORY AGENCY

    REF: (A) 05 WELLINGTON 119; (B) 04 WELLINGTON 596

    ¶1. (SBU) Begin summary:  Proposed rules for a new Australian-New
    Zealand regulatory agency for therapeutic products will make it
    costlier for U.S. makers of medical devices and complementary
    medicines to operate in New Zealand, according to the manufacturers'
    representatives.  They contend the proposed rules, issued May 23,
    would drive many of their products out of New Zealand.  In contrast,
    the pharmaceutical industry expects the agency would expedite the
    process for obtaining marketing approval for medicines and would
    save the industry in regulatory costs.  Its support of the agency,
    however, hinges on the New Zealand government continuing to allow
    direct-to-consumer advertising of prescription drugs, which is not
    allowed in Australia.  Meanwhile, the government does not yet have
    enough political support to pass the legislation necessary to set up
    the agency.  End summary.

    ¶2. (U) Australia and New Zealand signed an agreement in December
    2003 to provide unified regulation of prescription pharmaceuticals
    as well as therapeutic goods that have been virtually unregulated in
    New Zealand, including medical devices, over-the-counter medicines,
    dietary and nutritional supplements, and cosmetics and toiletries
    (ref B).  The proposed agency -- the Australia New Zealand
    Therapeutic Products Authority -- would replace the Australian
    Therapeutic Goods Administration (TGA) and the New Zealand Medicines
    and Medical Devices Safety Authority (Medsafe).  The deadline for
    public submissions on the draft rules is August 15.  The New Zealand
    government is hoping to introduce legislation in July to establish
    the agency and open the agency's doors in the second half of 2007.

    ¶3. (SBU) The agency's opening has been delayed a number of times
    previously (ref A), and passage of the implementing legislation is
    far from certain.  The Labour-led New
    Zealand government lacks the votes in Parliament to pass the
    legislation on its own and has no support yet from any other party.
    Some opponents are concerned about Australia's possible dominance of
    the agency, and others are worried that it would mean higher costs
    for industry and consumers in New Zealand.  Proponents say that New
    Zealand's participation in the joint agency would cost less than if
    it tried on its own to extend its regulatory authority to devices
    and other non-drug health products.

    Medical devices, complementary medicines
    ----------------------------------------
    ¶4. (SBU) Under the proposed rules, the agency would require licenses
    for all therapeutic goods and recover all its regulatory costs
    through fees and charges.  That would be particularly burdensome for
    New Zealand's medical device and complementary medicine sectors,
    which have not been required to obtain pre-market approval for their
    products and pay no licensing or other regulatory fees.  While the
    draft rules provide for a three-year transition period for product
    licenses to be obtained, industry representatives expect the fees to
    be so high that they will have to seek cheaper sources -- outside
    the United States -- for medical devices and complementary
    medicines.  They expect the fees to be similar to those already
    charged in Australia, which has a population and market roughly five
    times as large as New Zealand's.  They predict the compliance costs
    would force many smaller distributors and importers out of business
    in New Zealand.

    ¶5. (SBU) The draft rules also provide that the agency would conduct
    all conformity assessments for medical devices, including audits of
    manufacturers and testing of products to ensure they meet relevant
    standards, which also would increase the sector's costs.  Medical
    device representatives noted that the proposed agency would accept
    European certification, but not U.S. Food and Drug Administration
    certification.  As one representative said, that points to the need
    for a mutual recognition agreement between Australia and the United
    States, which presumably would enable the joint agency to accept FDA
    certification.

    ¶6. (SBU) The industry representatives said they support the agency
    in principle, recognizing the need for regulation of their products
    to ensure public safety.  However, they were disappointed that their
    years of consultations with the government about their concerns
    regarding a new regulatory regime were not reflected in the
    proposal.  They had hoped that the government at least would set
    fees according to the size of the product's market.

    Prescription drugs
    ------------------
    ¶7. (SBU) On the other hand, the pharmaceutical industry sees the

    WELLINGTON 00000475  002 OF 002

    joint agency as an improvement over New Zealand's existing small and
    overtaxed regulatory regime, in which obtaining marketing approval
    for prescription medicines can take more than three years.  The
    agency also could represent a cost-savings by providing a single
    point of entry for both markets, as opposed to requiring a product
    license in each country.  The industry is concerned, however, about
    whether labeling rules and other such requirements could be met
    within three years.  It is advocating a five-year transition period.

    ¶8. (SBU) The drug industry also says it will withdraw support of the
    agency if the New Zealand government uses it as an excuse to ban
    direct-to-consumer advertising (DTCA), which some firms have
    employed to boost sales of unsubsidized medicines in New Zealand's
    tightly restricted market.  Australia allows only disease-based,
    awareness-building advertising, while New Zealand is the only
    country in the world besides the United States that allows the
    pharmaceutical industry to promote its products directly to the
    public.  (The government is reviewing its policy on
    direct-to-consumer advertising of prescription medicines, in
    preparation for drafting new legislation on the regulation of DTCA.
    Such legislation is necessary because the law that would enable New
    Zealand to participate in the joint agency also would repeal the
    Medicines Act 1981, which allows DTCA.)

    Comment
    -------
    ¶9. (SBU) The joint agency's higher regulatory costs could lead to a
    decline in sales of U.S. medical devices and other therapeutic
    products in New Zealand.  Failure to recognize FDA certification
    also would add a discriminatory barrier to U.S. medical devices.
    While the need for improving regulation of therapeutic products in
    New Zealand should be acknowledged, post suggests these concerns be
    raised in the Trade and Investment Framework Agreement talks with
    New Zealand scheduled for July 27.

    MCCORMICK

`